Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu
    [{"orgOrder":0,"company":"DKSH","sponsor":"Alvotech","pharmaFlowCategory":"D","amount":"Undisclosed","upfrontCash":"Undisclosed","newsHeadline":"Alvotech and DKSH partner to bring key biosimilar to Asia","therapeuticArea":"Immunology","highestDevelopmentStatus":"Phase III","country":"SWITZERLAND","productType":"Large molecule","productStatus":"Biosimilar","date":"March 2020","url1":"","url2":"","graph1":"Immunology","graph2":"Phase III"},{"orgOrder":0,"company":"DKSH","sponsor":"Lupin Ltd","pharmaFlowCategory":"D","amount":"Undisclosed","upfrontCash":"Undisclosed","newsHeadline":"Lupin and DKSH Sign an Exclusive Licensing and Supply Agreement to Market Five Biosimilar Candidates in the Philippines","therapeuticArea":"Musculoskeletal","highestDevelopmentStatus":"Phase III","country":"SWITZERLAND","productType":"Large molecule","productStatus":"Biosimilar","date":"September 2022","url1":"","url2":"","graph1":"Musculoskeletal","graph2":"Phase III"},{"orgOrder":0,"company":"DKSH","sponsor":"Leo Pharma","pharmaFlowCategory":"D","amount":"Undisclosed","upfrontCash":"Undisclosed","newsHeadline":"LEO Pharma and DKSH Partner to Deliver Products and Solutions to People in Asia with Skin Conditions and Thrombosis","therapeuticArea":"Dermatology","highestDevelopmentStatus":"Phase III","country":"SWITZERLAND","productType":"Small molecule","productStatus":"New Molecular Entity","date":"September 2022","url1":"","url2":"","graph1":"Dermatology","graph2":"Phase III"},{"orgOrder":0,"company":"DKSH","sponsor":"Eisai","pharmaFlowCategory":"D","amount":"Undisclosed","upfrontCash":"Undisclosed","newsHeadline":"Eisai To Divest Rights For Muscle Relaxant Myonal\u00ae And Vertigo And Equilibrium Disturbance Treatment Merislon\u00ae In Asia To DKSH","therapeuticArea":"Neurology","highestDevelopmentStatus":"Approved","country":"SWITZERLAND","productType":"Small molecule","productStatus":"Approved","date":"November 2022","url1":"","url2":"","graph1":"Neurology","graph2":"Approved"},{"orgOrder":0,"company":"DKSH","sponsor":"Nuance Pharma","pharmaFlowCategory":"D","amount":"Undisclosed","upfrontCash":"Undisclosed","newsHeadline":"Nuance Pharma Announces Partnership With DKSH To Launch Bentrio\u2122 Nasal Spray In Hong Kong And Macau","therapeuticArea":"Immunology","highestDevelopmentStatus":"Approved","country":"SWITZERLAND","productType":"Small molecule","productStatus":"Approved","date":"November 2022","url1":"","url2":"","graph1":"Immunology","graph2":"Approved"}]

    Find Clinical Drug Pipeline Developments & Deals by DKSH

    Menu

    DKSH

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    INTERMEDIATES

    EXCIPIENTS

    EXCIPIENTS BY INGREDIENTS

    EXCIPIENTS BY APPLICATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Loading...

    All Data

    Previous
    Next
    Filters Filter
    ×
    FILTER:
    filter Company
      filter Sponsor
        filter Country
          filter Therapeutic Area
            filter Study Phase

              Active Filter(s):

              refreshFilters
              refreshReset Filter
              refresh Reset Filter
              price-trend All Developments

              Companies By Therapeutic Area

              Development Status

              DKSH

              Contact Supplier
              • Deals
              Virtual BoothDKSH is your trusted partner for companies looking to grow their business in Asia & beyond.
              Contact Supplier Contact Supplier
              Flag Switzerland
              Virtual Booth Virtual Booth
              Digital Content Digital Content

              Nuance Pharma Announces Partnership With DKSH To Launch Bentrio™ Nasal Spray In Hong Kong And Macau

              Details:

              Under the cooperation agreement, DKSH HK will provide full-agency services including key account management, marketing promotion, supply chain, and distribution for Bentrio (bentonite) Nasal Spray sales operation in Hong Kong and Macau.

              Lead Product(s): Bentonite,Mono Propylene Glycol,Citric Acid

              Therapeutic Area: Immunology Product Name: Bentrio

              Highest Development Status: Approved Product Type: Small molecule

              Recipient: Nuance Pharma

              Deal Size: Undisclosed Upfront Cash: Undisclosed

              Deal Type: Partnership November 28, 2022

              DKSH Company Banner

              CPhI China

              Booth #W5P10

              envelop Contact Supplier

              DKSH

              Contact Supplier
              • Deals
              Virtual BoothDKSH is your trusted partner for companies looking to grow their business in Asia & beyond.
              Contact Supplier Contact Supplier
              Flag Switzerland
              Virtual Booth Virtual Booth
              Digital Content Digital Content

              Eisai To Divest Rights For Muscle Relaxant Myonal® And Vertigo And Equilibrium Disturbance Treatment Merislon® In Asia To DKSH

              Details:

              Myonal (eperisone hydrochloride) is a muscle-relaxant which is used to treat neck-shoulder-arm syndrome and Merislon is approved to treat vertigo and dizziness associated with inner-ear disorders.

              Lead Product(s): Eperisone Hydrochloride

              Therapeutic Area: Neurology Product Name: Myonal

              Highest Development Status: Approved Product Type: Small molecule

              Recipient: Eisai

              Deal Size: Undisclosed Upfront Cash: Undisclosed

              Deal Type: Agreement November 07, 2022

              DKSH Company Banner

              CPhI China

              Booth #W5P10

              envelop Contact Supplier

              DKSH

              Contact Supplier
              • Deals
              Virtual BoothDKSH is your trusted partner for companies looking to grow their business in Asia & beyond.
              Contact Supplier Contact Supplier
              Flag Switzerland
              Virtual Booth Virtual Booth
              Digital Content Digital Content

              LEO Pharma and DKSH Partner to Deliver Products and Solutions to People in Asia with Skin Conditions and Thrombosis

              Details:

              The agreement will support both LEO Pharma’s strategy of building a simpler and more competitive organization and pipeline including its lead asset LP0133 (delgocitinib) and DKSH Business Unit Healthcare’s strategic focus of strengthening its regional footprint.

              Lead Product(s): Delgocitinib

              Therapeutic Area: Dermatology Product Name: LP0133

              Highest Development Status: Phase III Product Type: Small molecule

              Recipient: Leo Pharma

              Deal Size: Undisclosed Upfront Cash: Undisclosed

              Deal Type: Partnership September 29, 2022

              DKSH Company Banner

              CPhI China

              Booth #W5P10

              envelop Contact Supplier

              DKSH

              Contact Supplier
              • Deals
              Virtual BoothDKSH is your trusted partner for companies looking to grow their business in Asia & beyond.
              Contact Supplier Contact Supplier
              Flag Switzerland
              Virtual Booth Virtual Booth
              Digital Content Digital Content

              Lupin and DKSH Sign an Exclusive Licensing and Supply Agreement to Market Five Biosimilar Candidates in the Philippines

              Details:

              The biosimilars planned under this agreement include biosimilar of Prolia® (denosumab, AVT03), Xgeva® (denosumab), Simponi® (golimumab), and Eylea® (aflibercept) as well as two undisclosed proposed biosimilars for immunology and oncology.

              Lead Product(s): Denosumab

              Therapeutic Area: Musculoskeletal Product Name: AVT03

              Highest Development Status: Phase III Product Type: Large molecule

              Recipient: Lupin Ltd

              Deal Size: Undisclosed Upfront Cash: Undisclosed

              Deal Type: Licensing Agreement September 07, 2022

              DKSH Company Banner

              CPhI China

              Booth #W5P10

              envelop Contact Supplier

              DKSH

              Contact Supplier
              • Deals
              Virtual BoothDKSH is your trusted partner for companies looking to grow their business in Asia & beyond.
              Contact Supplier Contact Supplier
              Flag Switzerland
              Virtual Booth Virtual Booth
              Digital Content Digital Content

              Alvotech and DKSH partner to bring key biosimilar to Asia

              Details:

              Under the partnership, Alvotech Hf will be responsible for the development and supply of AVT02, while DKSH will oversee its registration and commercialization.

              Lead Product(s): Adalimumab

              Therapeutic Area: Immunology Product Name: Undisclosed

              Highest Development Status: Phase III Product Type: Large molecule

              Recipient: Alvotech

              Deal Size: Undisclosed Upfront Cash: Undisclosed

              Deal Type: Partnership March 24, 2020

              DKSH Company Banner

              CPhI China

              Booth #W5P10

              envelop Contact Supplier

              DKSH
              Send me more info on How To Grow My Business Digitally?
              Post Enquiry
              POST ENQUIRY